4.3 EFFECT OF LURASIDONE ON BODY WEIGHT AND LABORATORY PARAMETERS IN ADOLESCENT PATIENTS WITH SCHIZOPHRENIA: RESULTS FROM A 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Objectives: To evaluate the effect of short-term treatment with lurasidone on body weight, metabolic parameters, and prolactin levels in adolescent patients with schizophrenia. Methods: In a multicenter, placebo-controlled study, adolescents (13-17 years old) with schizophrenia (DSM-IV-TR criteria)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American Academy of Child and Adolescent Psychiatry 2016-10, Vol.55 (10), p.S163-S163
Hauptverfasser:	Goldman, Robert S., PhD, Robb, Adelaide S., MD, Silva, Robert M., PhD, Cucchiaro, Josephine B., PhD, Deng, Ling, PhD, Loebel, Antony, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescents Body weight Child & adolescent psychiatry Cholesterol Clinical trials Glucose Lipids Mental disorders Parameters Patients Pediatrics Physiological psychology Placebo effect Prolactin Psychiatry Psychopharmacology Psychotropic drugs Safety Schizophrenia Therapeutic applications Triglycerides
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!